Introduction
A new observational study suggests people taking GLP-1 weight loss and diabetes drugs may face slightly higher rates of osteoporosis and gout over time. The research, led by Dr....
Affordable access to lenacapavir
A twice-yearly HIV prevention injection, lenacapavir, will soon be available for just $40 per patient per year in 120 low- and...
Modest advances with new drugs
After decades of stalled progress, two treatments — Eli Lilly’s donanemab and Biogen and Eisai’s lecanemab — have shown the...
Ultra-processed foods (UPFs) are increasingly targeted in public health debates, linked to obesity, dementia, and what some describe as a food addiction crisis. Critics...